Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation

Ítems similars

• Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation
  per: Steinbicker, Andrea U., et al.
  Publicat: (2011)
• Inhibition of Bone Morphogenetic Protein Signal Transduction Prevents the Medial Vascular Calcification Associated with Matrix Gla Protein Deficiency
  per: Malhotra, Rajeev, et al.
  Publicat: (2015)
• BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism
  per: Mayeur, Claire, et al.
  Publicat: (2014)
• Bone morphogenetic protein signaling in inflammation
  per: Wu, David H, et al.
  Publicat: (2019)
• Deletion of the Sequence Encoding the Tail Domain of the Bone Morphogenetic Protein type 2 Receptor Reveals a Bone Morphogenetic Protein 7-Specific Gain of Function
  per: Leyton, Patricio A., et al.
  Publicat: (2013)